Docetaxel (TaxotereTM), a Novel Taxoid, in the Treatment of Advanced Colorectal Carcinoma: An EORTC Early Clinical Trials Group Study

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1994.309
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

EO9 Phase II Study in Advanced Breast, Gastric, Pancreatic and Colorectal Carcinoma by the EORTC Early Clinical Studies Group

European Journal of Cancer
Cancer ResearchOncology
1996English

A Phase II Study of Paclitaxel in Advanced Bronchioloalveolar Carcinoma (EORTC Trial 08956)

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2005English

Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective

Canadian Urological Association Journal
Urology
2013English

A Clinical Study of Locally Advanced Carcinoma of Breast

Journal of Evidence Based Medicine and Healthcare
2015English

High-Dose Epirubicin Is Not an Alternative to Standard-Dose Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. A Study of the EORTC Soft Tissue and Bone Sarcoma Group

British Journal of Cancer
Cancer ResearchOncology
1998English

FOLFIRINOX for the Treatment of Colorectal Cancer: Latest Evidence From Clinical Trials

Colorectal Cancer
OncologyGastroenterology
2012English

Advanced Colorectal Carcinoma With Testicular Metastasis in an Adolescent: A Case Report

Journal of Medical Case Reports
Medicine
2018English

Clinical Study of Early Rectal Carcinoma.

Nippon Daicho Komonbyo Gakkai Zasshi
1989English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy